About this trial
Visual acuity tests, commonly conducted in clinics and used for health screenings, are becoming more in demand due to an aging population. Current online self-eye check apps are limited as they don\'t accurately reflect true distance vision assessed in clinical settings. These tests, performed by trained personnel, are time-consuming and can cause delays in clinics. This project aims to develop an automated Visual Acuity (VA) station using AI technologies like speech-to-text and computer vision, hypothesizing that it can match the accuracy of manual assessments by clinic staff, thus potentially reducing waiting times and improving efficiency.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients age >21 and able to give consent
Patients who have at least counting finger vision
Patients who is able to speak in an audible and clear voice
Patients who is able to use a digital device independently (e.g. handphone)
Disqualifiers
Patients on wheelchair/ walking aids
Patients with hearing difficulties
Patients with speech difficulties
Patients who have cognitive impairment
Trial design
Single group
Treatments tested in this trial
Automated visual acuity
DeviceThe automated visual acuity device is developed in collaboration with Tan Tock Seng Hospital, Singapore Institute of Technology and Nanyang Technological University. It uses artificial intelligence for pose estimation and speech recognition to infer if the participant is reading the correct letters displayed on the screen.
Treatment groups
Trial outcomes
Primary outcomes
Best corrected visual acuity with and without pinhole using Snellen letters and numbers
Best corrected visual acuity will be expressed in metres (e.g. 6/6-1), and will be converted to LogMAR for analysis.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Tan Tock Seng Hospital
Lead sponsor
Singapore Institute of Technology
Collaborator
Nanyang Technological University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: